Nucleosides, especially pyrimidines modified in the C5-position, can act as radiosensitizers via a mechanism that involves their enzymatic triphosphorylation, incorporation into DNA, and a subsequent dissociative electron attachment (DEA) process. In this paper, we report 5-iodo-4-thio-2′-deoxyuridine (ISdU) as a compound that can effectively lead to ionizing radiation (IR)-induced cellular death, which is proven by a clonogenic assay. The test revealed that the survival of cells, pre-treated with 10 or 100 µM solution of ISdU and exposed to 0.5 Gy of IR, was reduced from 78.4% (for non-treated culture) to 67.7% and to 59.8%, respectively. For a somewhat higher dose of 1 Gy, the surviving fraction was reduced from 68.2% to 54.9% and to 40.8% for incubation with 10 or 100 µM ISdU, respectively. The cytometric analysis of histone H2A.X phosphorylation showed that the radiosensitizing effect of ISdU was associated, at least in part, with the formation of double-strand breaks. Moreover, the cytotoxic test against the MCF-7 breast cancer cell line and human dermal fibroblasts (HDFa line) confirmed low cytotoxic activity of ISdU. Based on the results of steady state radiolysis of ISdU with a dose of 140 Gy and quantum chemical calculations explaining the origin of the MS detected radioproducts, the molecular mechanism of sensitization by ISdU was proposed. In conclusion, we found ISdU to be a potential radiosensitizer that could improve anticancer radiotherapy.
核苷,尤其是在C5位置改性的
嘧啶,可以通过其酶促
三磷酸化、纳入DNA和随后的解离性电子附着(
DEA)过程作为放射增敏剂。在本文中,我们报告5-
碘-4-
硫-2'-脱氧尿
嘧啶(ISdU)是一种可以有效引起电离辐射(IR)诱导的
细胞死亡的化合物,这已通过克隆形成实验证明。测试显示,预处理10或100微米ISdU溶液并暴露于0.5格雷(Gy)IR的细胞的存活率从未经处理的
培养基的78.4%降至67.7%和59.8%。对于稍高的1 Gy剂量,存活率从68.2%降至分别为54.9%和40.8%的10或100微米ISdU孵育。组蛋白H2A.X
磷酸化的细胞学分析表明,ISdU的放射增敏效应至少部分与双链断裂的形成有关。此外,对MCF-7乳腺癌
细胞系和人类皮肤成纤维细胞(HDFa系)的细胞毒性测试证实了ISdU的低细胞毒性活性。根据ISdU的稳态辐解和量子
化学计算的结果,解释了MS检测到的放射性产物的起源,提出了ISdU的增敏分子机制。总之,我们发现ISdU是一种潜在的放射增敏剂,可以改善抗癌放射治疗。